Skribe Medical

What they do

Skribe Medical announced its selection for the FDA READI-Home innovation program in a November 11, 2026 release. It is developing wearable cardiac assessment for people receiving cancer treatment. Program participation is not FDA marketing authorization. The release discloses a previously raised $1.65 million pre-seed round led by SeaX Ventures with GoAhead Ventures and Marin Sonoma Impact Ventures. November 11 is the disclosure date, not a verified date of a new financing close. Ryan Neely, PhD is co-founder and CEO.

People in this update

• Ryan NeelyCo-founder and CEOSource

The record

Vertical

Wearables & Remote Monitoring

Sub-segment

Wearable cardiac assessment

Product type

Platform software

Stage

Pre-seed

Headquarters

Not disclosed

Region

Founded

Not disclosed

Total funding

$1.65M raised

Notable investors: SeaX Ventures, GoAhead Ventures, Marin Sonoma Impact Ventures.